Navigation Links
Zimmer Holdings, Inc. Agrees to Sell $1 Billion of Senior Notes

WARSAW, Ind., Nov. 12 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has agreed to sell $1.0 billion of its senior unsecured notes in an underwritten public offering consisting of $500.0 million of 4.625% notes due 2019 and $500.0 million of 5.75% notes due 2039. The 10-year notes were priced to yield 118 basis points above their Treasury benchmark, and the 30-year notes were priced at 135 basis points above their Treasury benchmark. The offering is expected to close on November 17, 2009.

The Company intends to use the net proceeds of the offering to repay the outstanding U.S. dollar denominated balance of its credit facility and for general corporate purposes, including the financing of its stock repurchase program.

Copies of the prospectus may be obtained by calling or e-mailing Banc of America Securities LLC at 1-800-294-1322 or, by calling Citigroup Global Markets Inc. toll free at 1-877-858-5407, or by calling J.P. Morgan Securities Inc. at (212) 834-4533.

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

This press release contains forward-looking statements regarding our intended use of proceeds and the anticipated closing of the notes offering, which are subject to risks and uncertainties, including the general economic conditions and other risks and uncertainties described in our Annual Report on Form 10-K for the year ended December 31, 2008 and subsequent quarterly reports. Actual results may differ materially from anticipated results. We do not undertake to update any forward-looking statements.

For more information about Zimmer, visit

SOURCE Zimmer Holdings, Inc.

SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results
2. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
3. NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company
4. China Biopharmaceuticals Holdings, Inc. Shareholders Overwhelmingly Support Merger with NeoStem, Inc., a NYSE AMEX Listed Company Trading Under Symbol NBS
5. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Fourth Quarter Earnings and 2010 Financial Guidance Webcast
6. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
7. Faced With Federal Prosecution, MountainView Agrees to Stop Harassment of RNs in Settlement With Labor Board
8. Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
9. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
10. Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014
11. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
Post Your Comments:
(Date:12/1/2015)... --  MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), a ... an Investigational New Drug Application (IND) with the U.S. ... fully human antibody product HuMab 5B1 as a therapeutic ... the Phase I clinical trial early in 2016. ... planned Phase I trial will evaluate the safety, tolerability ...
(Date:12/1/2015)... 2015  Booth #3506 – Claymount is featuring its full ... of the Radiological Society of North America ... Based in the Netherlands , Claymount is ... (NYSE: VAR ) and is one of the world,s ... state automatic exposure control systems for controlling dose during medical ...
(Date:12/1/2015)... , Dec. 1, 2015  Lexicon Pharmaceuticals, ... that top-line data from its TELECAST Phase ... in treating carcinoid syndrome in cancer patients ... clinical benefit observed in its pivotal TELESTAR ... a companion to TELESTAR primarily to provide ...
Breaking Medicine Technology:
(Date:12/1/2015)... Viejo, CA (PRWEB) , ... December 01, 2015 , ... ... length of footage, and with full control over customization, the possibilities are truly endless, ... frame rate, position randomization, overlay depth position, vertical flip, horizontal flip, depth of field ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This prestigious ... care experience, and propose exciting enhancements to the medical landscape. , The UCLH ...
(Date:11/30/2015)... Cary, NC (PRWEB) , ... November 30, 2015 ... ... Dominique Dawes, Amanda Beard and Brooke Bennett are collaborating with brands across various ... , These four influential figures make up an elite group of Gold Medal ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... programs of the19th Bi-National Convention of the Federation of Philippine American Chambers of ... in Las Vegas, Nevada. , 1Heart Caregiver Services, as an active delegate ...
Breaking Medicine News(10 mins):